Zimmer Biomet Holdings, Inc. · NYSE:ZBH

Zimmer Biomet — Merger or Acquisition (June 2016)

14 slides from Zimmer Biomet's merger presentation, Jun 7, 2016

  1. Slide 1: Zimmer Biomet Announces Agreement to Acquire LDR

    Zimmer Biomet Announces Agreement to Acquire LDR David Dvorak President and CEO Christophe Lavigne LDR Co-Founder, Chairman, President and CEO Dan Florin SVP and CFO Adam Johnson Group President, Spine, CMF and Thoracic, and Dental June 7, 2016 Exhibit 99.2

  2. Slide 2: Cautionary Statement Regarding Forward-Looking Statements

    Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking information related to Zimmer Biomet, LDR and the acquisition of LDR by Zimmer Biomet that involves substantial risks and uncertainties that could cause actual results to differ materially from thos

  3. Slide 3: Agenda

    Spine Market 3 Agenda Transaction Summary 4 Transaction Overview 1 Overview of LDR 2

  4. Slide 4: Highly Complementary Strategic Transaction

    Highly Complementary Strategic Transaction Highly strategic and complementary acquisition that strengthens one of Zimmer Biomet’s key franchises: Spine Accelerated growth in the $10 billion Spine market, enabling Zimmer Biomet to gain a leading position in its fastest growing segment Creates compreh

  5. Slide 5: Transaction Overview

    Purchasing LDR for $37.00 per share in cash via tender offer Total purchase price ~$1.0 billion Price ~5.5x 2016 revenue (midpoint of LDR management full-year revenue guidance) Valuation Expected close in third quarter of 2016 Subject to customary closing conditions Timing Adjusted diluted EPS 2017:

  6. Slide 6: LDR At-A-Glance

    Overall Trial Success Through 5 Years Focus on Spine Two Exclusive Technology Platforms ü Mobi-C® ü MIVoTM Represented over 92% of Revenue in 2015 Attractive Financial Profile $164M Revenue in 2015 21% Growth CC in 2015 v 2014 83.4% Gross Margin in 2015 Geographic Mix U.S.: 81% Revenue in 2015 OUS:

  7. Slide 7: Mobi-C Cervical Disc Replacement Device

    Mobi-C Cervical Disc Replacement Device First and only artificial cervical disc approved in the U.S. for both one- and two-level indication U.S. Approval in August 2013 PMAs started in 2005 One of the largest prospective, randomized clinical studies ever completed in spine ~600 patients: 24 centers

  8. Slide 8: Current U.S. Cervical Disc Replacement Market Opportunity

    Current U.S. Cervical Disc Replacement Market Opportunity Mobi-C is uniquely well-positioned to be the market leader: The first and currently only on label two-level indication Overall superiority claim for two-level application through 5 years Over 450 issued patents worldwide Simplified surgical t

  9. Slide 9: LDR: Revenue Through Exclusive Technology

    LDR: Revenue Through Exclusive Technology 21% CAGR – Total Revenue 129% CAGR – Mobi-C 16% Growth 2015 v 2014 (21% CC) Source: LDR ($ in millions) $

  10. Slide 10: Snapshot of Today's Spine Market

    Largest musculoskeletal market: *~$10bn Fastest growing segments Cervical Disc MIS Complex Spine Market dynamics are favorable Demographics driving volume growth globally Market share shifts driven by differentiated technologies and unique products Snapshot of Today’s Spine Market Spine Market Share

  11. Slide 11: Comprehensive Spine Portfolio

    Comprehensive Spine Portfolio Acquisition will create a comprehensive Spine portfolio, adding high growth cervical disc replacement and zero profile fusion products Complex Spine and Biologics MIS Cervical Disc Replacement Exclusive Technology Platforms Existing Portfolio

  12. Slide 12: Financial Summary

    Financial Summary Accelerates top-line growth with sustainable differentiated platform in Spine, the largest musculoskeletal market Prudent use of cash and new borrowing under revolving credit facility to fund the transaction – expect to launch debt offering in Q3 to repay credit facility Expect to

  13. Slide 13: Transaction Summary

    Transaction Summary Highly strategic and complementary acquisition that strengthens one of Zimmer Biomet’s key franchises: Spine Accelerated growth in the $10 billion Spine market, enabling Zimmer Biomet to gain a leading position in its fastest growing segment Creates comprehensive Spine portfolio

  14. Slide 14: Questions & Answers

    Questions & Answers @ zimwer Biomer

Zimmer Biomet Holdings — Merger or Acquisition (June 2016) on 6ix